The Alabama Vaccine Research Clinic at UAB are seeking volunteers for a phase 1 HIV prevention study. This study tests the body’s immune system response to, a protein similar to what is found in HIV. The immune response prepares the body to recognize the same protein in HIV and fight the virus if a person is exposed to HIV in the future. Participants will be compensated over $750 for their efforts.

If you are interested, please call 205-934-6777 or email avrc@uabmc.edu.
You can also fill out our contact form at https://sites.uab.edu/avrc/contact-us/
Published in Clinical Trials
In a talk at UAB on March 6, the NIH director shared his thoughts on exceptional opportunities for science and young scientists — and highlighted several exciting UAB projects.
Published in Campus News
You may qualify to participate in a national research study to evaluate the safety and effectiveness of the shingles vaccine (Zostavax®). Are you at least 50 years old? Are you taking Remicade, Enbrel, Humira, Cimzia or Simponi? If yes, and if you have never received the shingles vaccine, you may qualify. The duration of the study is 6 months. Participants will be compensated. Zostavax ® is an approved vaccine for people ages 50 and older and has been shown to be very effective to prevent zoster (shingles) and related complications. However it has NOT been studied in patients who are taking Remicade, Enbrel, Humira, Cimzia or Simponi. The Varicella zostER VaccinE Study (VERVE) has been approved by the Food and Drug Administration (FDA). UAB is coordinating the VERVE study. For more information, please call (205) 934-2993 or email verve@uab.edu
Published in Clinical Trials
Have you had recurrent BV (bacterial vaginal infections) 2 or more times in the past 12 months?  We are conducting a sexual partner study for treatment of the female and male sexual partners as a way to prevent BV. Medication at no cost to you. Couples can receive up to $300. Joy, 205-996-2780
Published in Clinical Trials